Global Biologics Market - Detailed Analysis of Current Industry Figures and 2027 Foresight Report
Biologics market is at risk over the forthcoming years due to leading biologic drugs expected to lose exclusivity over the next few years. The patented biologic drugs are expected to be replaced by biosimilar drugs. Competition is expected to be limited in the market as the drugs are expected to be formed using various types of innovative technologies. Increasing geriatric population, early onset of ageing, increasing awareness for technologically advanced medical procedures and drugs, higher spending power, and rising incidence...
View full press release